GBCA Certification, The Braeside Spec 2 Facility, Victoria

March 2021 

The Braeside Spec 2 facility in Victoria, Australia, has achieved a 5 Star As Built certification from the Green Building Council of Australia (GBCA). This is the first facility to be rated using the newer Design & As Built v1.2 rating tool.

 

Leased to Gale Pacific and Toll, the facility features 100kW of on-site solar, expected to generate 128,792kWh annually. Combined with efficient LED lighting throughout the warehouse and office spaces, this is expected to reduce the peak electricity demand by 72%.

 

2 x 25kL rainwater tanks, and water-efficient fixtures and fittings have been installed to reduce potable water consumption by 85% compared to a standard practice building.

 

Congratulations to Rodney David and Steve Kakavoules on their hard work to deliver another Green Star certified facility.

Related News

03.11.25

Capital partnership with Morgan Stanley Real Estate Investing in Australia expanded

Frasers Property has expanded its Australian capital partnership with investment vehicles sponsored by Morgan Stanley Real Estate Investing (“MSREI”), to include a portfolio of nine industrial assets from Frasers Property Industrial.

30.10.25

VastHub on track

VastHub, our new industrial and logistics park in Germany, is on track with preparations for certified demolition of old builds underway.

23.10.25

2025 GRESB Benchmarks released

Congratulations to our teams for their hard work securing our results for the 2025 GRESB Benchmark.

16.10.25

Horsley Park site on exhibition

After several years of collaboration with the Fairfield City Council and the NSW Government, we’re excited to share that our proposed Canopy estate in Horsley Park is now on public exhibition.

15.10.25

Five new solar installations set for Germany

Sunrock recently completed our largest solar installation in Europe at The Tube in Germany and we are proud to work with them again on five more solar PV installations across our portfolio.

It helps to stay informed and ahead.
Subscribe to our latest news.